Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 411

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

Open access
Shahzad, Khurrum, Bock, Fabian, Dong, Wei, Wang, Hongjie, Kopf, Stefan, Kohli, Shrey, Al-Dabet, Moh'd Mohanad, Ranjan, Satish, Wolter, Juliane, Wacker, Christian, Biemann, Ronald, Stoyanov, Stoyan, Reymann, Klaus, Söderkvist, Peter, Groß, Olaf, Schwenger, Vedat, Pahernik, Sascha, Nawroth, Peter P., Gröne, Herman-Josef, Madhusudhan, Thati, Isermann, Berend·2015·Kidney International

Abstract

Diabetic nephropathy is a growing health concern with characteristic sterile inflammation. As the underlying mechanisms of this inflammation remain poorly defined, specific therapies targeting sterile inflammation in diabetic nephropathy are lacking. Intriguingly, an association of diabetic nephropathy with inflammasome activation has recently been shown, but the pathophysiological relevance of this finding remains unknown. Within glomeruli, inflammasome activation was detected in endothelial cells and podocytes in diabetic humans and mice and in glucose-stressed glomerular endothelial cells and podocytes in vitro. Abolishing Nlrp3 or caspase-1 expression in bone marrow-derived cells fails to protect mice against diabetic nephropathy. Conversely, Nlrp3-deficient mice are protected against diabetic nephropathy despite transplantation of wild-type bone marrow. Pharmacological IL-1R antagonism prevented or even reversed diabetic nephropathy in mice. Mitochondrial reactive oxygen species (ROS) activate the Nlrp3 inflammasome in glucose or advanced glycation end product stressed podocytes. Inhibition of mitochondrial ROS prevents glomerular inflammasome activation and nephropathy in diabetic mice. Thus, mitochondrial ROS and Nlrp3-inflammasome activation in non-myeloid-derived cells aggravate diabetic nephropathy. Targeting the inflammasome may be a potential therapeutic approach to diabetic nephropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ki.2014.271

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 411

Metadata

Authors
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., Biemann, R., Stoyanov, S., Reymann, K., Söderkvist, P., Groß, O., Schwenger, V., Pahernik, S., Nawroth, P. P., Gröne, H.-J., Madhusudhan, T., & Isermann, B.
Venue
Kidney International
Publisher
Elsevier BV
Published
2015-01
Volume
87
Issue
1
Pages
74-84
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2080717362
Cited by
411
References
58
FWCI
9.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. https://app.cochat.ai/papers/10.1038/ki.2014.271
The paper
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., Biemann, R., Stoyanov, S., Reymann, K., Söderkvist, P., Groß, O., Schwenger, V., Pahernik, S., Nawroth, P. P., Gröne, H.-J., . . . Isermann, B. (2015). Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney International. https://doi.org/10.1038/ki.2014.271

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.